Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CCID Consulting Co | CCX | Nov 27, 2024 | 0.09 | 0.00 |
CCL Industries Inc. | 1C9 | Nov 27, 2024 | 51.50 | -0.96 |
CCS Abwicklungs AG | C0M | Nov 27, 2024 | 0.12 | +0.17 |
CD Projekt S.A. | 7CD | Nov 27, 2024 | 38.82 | -0.05 |
CD Projekt S.A. American Depositary Receipts - Unsponsored ( | 7CD0 | Nov 27, 2024 | 9.70 | +3.74 |
CDAX (Performanceindex) | CDAX | Nov 27, 2024 | 1 657.29 | -0.29 |
CDN Maverick Capital Corp | 338B | Nov 27, 2024 | 0.09 | +2.22 |
CDW Corporation | CDW | Nov 27, 2024 | 165.60 | -1.58 |
CECO Environmental Corp. | WCE | Nov 27, 2024 | 30.66 | -1.73 |
Ceconomy AG American Depositary Receipts - Unsponsored | MEOD | Nov 27, 2024 | 0.55 | -2.68 |
Ceconomy AG. | CEC | Nov 27, 2024 | 3.04 | +2.22 |
Cedergrenska | 41C | Nov 27, 2024 | 2.22 | 0.00 |
Cegedim | C7E | Nov 27, 2024 | 10.65 | -0.93 |
Cel-Sci Corp. | LSRM | Nov 27, 2024 | 0.57 | -5.82 |
Celanese Corp | DG3 | Nov 27, 2024 | 69.20 | -5.36 |
Celestica, Inc. | CTW0 | Nov 27, 2024 | 78.50 | -5.42 |
CELL IMPACT AB | ICLA | Nov 27, 2024 | 0.01 | 0.00 |
CellaVision | C26 | Nov 27, 2024 | 18.30 | -2.45 |
Cellcom Israel Limited | F5U | Nov 27, 2024 | 4.74 | 0.00 |
Celldex Therapeutics, Inc. | TCE2 | Nov 27, 2024 | 25.20 | -5.26 |
Cellectar Biosciences | NV4 | Nov 27, 2024 | 1.44 | -0.69 |
Cellectis | ZVA | Nov 27, 2024 | 1.96 | +14.22 |
Cellectis S.A. - American Depositary Shares | ZVAA | Nov 27, 2024 | 1.93 | +7.22 |
CELLINK B | 49Z | Nov 27, 2024 | 2.97 | +14.23 |
Cellnex Telecom S.A. | 472 | Nov 27, 2024 | 33.17 | +0.52 |
Cellnex Telecom SA Unsponsored ADR (Spain) | 4720 | Nov 27, 2024 | 15.80 | -0.63 |
Cellular Goods Plc | 6XS | Nov 27, 2024 | 0.00 | 0.00 |
Celon Pharma SA | 8RP | Nov 27, 2024 | 5.98 | +0.34 |
Celsion Corporation | CBO | Nov 27, 2024 | 0.80 | +4.61 |
Celsius Resources Limited | FX8 | Nov 27, 2024 | 0.01 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.